Section 4 - Secondary Anemias
Published online by Cambridge University Press: 18 April 2018
- Type
- Chapter
- Information
- AnemiaPathophysiology, Diagnosis, and Management, pp. 167 - 216Publisher: Cambridge University PressPrint publication year: 2017
References
References
Sullivan, PS, Hanson, DL, Chu, SY, et al. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998; 91:301.Google Scholar
Mocroft, A, Kirk, O, Barton, SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group. AIDS. 1999; 13:943.Google Scholar
Creagh, T, Mildvan, D. Greater prevalence of anemia in women and African Americans with HIV/AIDS in the CART era: a study of 10,000 patients. The Anemia Prevalence Study Group, In: Program and Abstracts of the 40th Annual Meeting of the Infectious Diseases Society of America (Chicago). Alexandria, VA: Infectious Diseases Society of America; 2002:127.Google Scholar
Revell, P, O’Doherty, MJ, Tang, A, Savidge, GF. Folic acid absorption in patients infected with the human immunodeficiency virus. J Intern Med. 1991; 230:227.CrossRefGoogle ScholarPubMed
Burkes, RL, Cohen, H, Krailo, M, et al. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol. 1987; 38:141.Google Scholar
Harriman, GR, Smith, PD, Horne, MK, et al. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1989; 149:2039.Google Scholar
Behler, C, Shade, S, Gregory, K, et al. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retroviruses. 2005; 21:200.Google Scholar
Richman, DD, Fischl, MA, Grieco, MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987; 317:192.Google Scholar
Mira, JA, López-Cortés, LF, Merino, D, et al. Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients. Antivir Ther. 2007; 12:1225.Google Scholar
McGinniss, MH, Macher, AM, Rook, AH, Alter, HJ. Red cell autoantibodies in patients with acquired immune deficiency syndrome. Transfusion. 1986; 26:405.CrossRefGoogle ScholarPubMed
Lai, M, Visconti, E, D’Onofrio, G, et al. Lower hemoglobin levels in human immunodeficiency virus-infected patients with a positive direct antiglobulin test (DAT): relationship with DAT strength and clinical stages. Transfusion. 2006; 46:1237.CrossRefGoogle ScholarPubMed
Abkowitz, JL, Brown, KE, Wood, RW, et al. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis. 1997; 176:269.CrossRefGoogle ScholarPubMed
Hawkins, CC, Gold, JW, Whimbey, E, Kiehn, TE, Brannon, P, Cammarata, R, Brown, AE, Armstrong, D. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Aug;105(2):184–188.CrossRefGoogle ScholarPubMed
Mootsikapun, P, Srikulbutr, S. Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome. Int J Infect Dis. 2006; 10:66.CrossRefGoogle ScholarPubMed
Scadden, DT, Zon, LI, Groopman, JE. Pathophysiology and management of HIV-associated hematologic disorders. Blood. 1989; 74:1455.Google Scholar
Shen, H, et al. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J Virol. 1999; 73:728.Google Scholar
Folks, TM, Kessler, SW, Orenstein, JM, et al. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science. 1988; 242:919.Google Scholar
Chelucci, C, Hassan, HJ, Locardi, C, et al. In vitro human immunodeficiency virus-1 infection of purified hematopoietic progenitors in single-cell culture. Blood. 1995; 85:1181.Google Scholar
Molina, JM, Scadden, DT, Sakaguchi, M, et al. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood. 1990; 76:2476.CrossRefGoogle ScholarPubMed
Carter, CC, et al. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med. 2010; 16:446.Google Scholar
Nixon, CC, Vatakis, DN, et al. HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice. Blood. 2013; 122:2195.CrossRefGoogle ScholarPubMed
Josefsson, L, et al. Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. JID. 2012; 206:28.Google Scholar
Redd, AD, Avalos, A, Essex, M. Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa. Blood. 2007; 110:3143.CrossRefGoogle Scholar
Karcher, DS, Frost, AR. The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. Am J Clin Path. 1991; 95:63.Google Scholar
Thiele, J, et al. Megakaryocytopoiesis in bone marrow biopsies of patients with acquired immunodeficiency syndrome (AIDS). An immunohistochemical and morphometric evaluation with special emphasis on myelodysplastic features and precursor cells. Pathol Res Pract. 1992; 188:722.Google Scholar
Costantini, A, Giuliodoro, S, Butini, L, et al. Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. J Acquir Immune Defic Syndr. 2009; 52:70.Google Scholar
Vanasse, GJ. Berliner, N. Anemia in elderly patients: an emerging problem for the 21st century. Hematology Am Soc Hematol Educ Program. 2010:271–275.CrossRefGoogle Scholar
Vanasse, GJ. Jeong, JY. Tate, J. A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease. Blood. 2011:118(20):5401–5408.Google Scholar
Redig, A. Berliner, N. Pathogenesis and clinical implications of HIV-related anemia in 2013. Hematology. 2013; 1 377–381.Google Scholar
Darko, DF. McCutchan, JA. Kripke, DF. Gillin, JC. Golshan, S. Fatigue, sleep disturbance, disability, and indices of progression of HIV infections. Am J Psychiatry. 1992; 149:514–520.Google Scholar
Abrams, DL. Steinhart, C. Frascino, R. Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life. Int J STD AIDS. 2000; 11:659–665.Google Scholar
Spivak, JL, Bender, BS, Quinn, TC. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med. 1984; 77:224.Google Scholar
Castella, A, Croxson, TS, Mildvan, D, et al. The bone marrow in AIDS. A histologic, hematologic, and microbiologic study. Am J Clin Pathol. 1985; 84:425.Google Scholar
Kilby, JM, Marques, MB, Jaye, DL, et al. The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections. Am J Med. 1998; 104:123.CrossRefGoogle ScholarPubMed
Berhane, K, Karim, R, Cohen, MH, et al. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women’s Interagency HIV Study. J Acquir Immune Defic Syndr. 2004; 37:1245.CrossRefGoogle Scholar
Fregonese, F, Collins, IJ, Jourdain, G, et al. Predictors of 5-year mortality in HIV-infected adults starting highly actrive antiretroviral therapy in Thailand. J Acquir Immune Defic Syndr. 2012; May 1; 60 91–98.Google Scholar
Phair, JP, Abels, RI, McNeill, MV, Sullivan, DJ. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall Results. Arch Intern Med. 1993; 153:2669.CrossRefGoogle ScholarPubMed
Grossman, HA, Goon, B, Bowers, P, et al. Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic HIV-infected patients. J Acquir Immune Defic Syndr. 2003; 34:368.Google Scholar
Mudido, PM, Georges, D, Dorazio, D, et al. Human immunodeficiency virus type 1 activation after blood transfusion. Transfusion. 1996; 36:860.Google Scholar
References
Caro, JJ, Salas, M, Ward, A, Goss, G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001; 91: 2214–2221.Google Scholar
Ludwig, H, Van Belle, S, Barrett-Lee, P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. European Journal of Cancer. 2004; 40:2293–2306.CrossRefGoogle ScholarPubMed
Tonia, T, Mettler, A, Robert, N, et al. Erythropoietin or darbepoetin for patients with cancer. Cochrane Database of Systematic Reviews. 2012; 12:CD003407.Google ScholarPubMed
Knight, K, Wade, S, Balducci, L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. The American Journal of Medicine. 2004; 116 Suppl 7A:11S–26S.Google Scholar
Groopman, JE, Itri, LM. Chemotherapy-induced anemia in adults: incidence and treatment. Journal of the National Cancer Institute. 1999; 91:1616–1634.Google Scholar
Spivak, JL. The anaemia of cancer: death by a thousand cuts. Nature Reviews Cancer. 2005; 5:543–555.Google Scholar
Maccio, A, Madeddu, C, Massa, D, et al. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia. Blood. 2005; 106:362–367.CrossRefGoogle Scholar
Hohaus, S, Massini, G, Giachelia, M, et al. Anemia in Hodgkin’s lymphoma: the role of interleukin-6 and hepcidin. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2010; 28:2538–2543.Google Scholar
Tisi, MC, Bozzoli, V, Giachelia, M, et al. Anemia in diffuse large B cell non-Hodgkin Lymphoma: the role of IL-6, hepcidin and erythropoietin. Leukemia & Lymphoma. 2013.Google Scholar
Sharma, S, Nemeth, E, Chen, YH, et al. Involvement of hepcidin in the anemia of multiple myeloma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2008; 14:3262–3267.Google Scholar
Santos, FP, Alvarado, Y, Kantarjian, H, et al. Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib. Cancer. 2011; 117:982–991.Google Scholar
Van Glabbeke, M, Verweij, J, Casali, PG, et al. Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: a study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG). European Journal of Cancer. 2006; 42:2277–2285.Google Scholar
Funakoshi, T, Latif, A, Galsky, MD. Risk of hematologic toxicities in cancer patients treated with sunitinib: A systematic review and meta-analysis. Cancer Treatment Reviews. 2013; 39:818–830.CrossRefGoogle ScholarPubMed
Goodnough, LT, Nemeth, E, Ganz, T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010; 116:4754–4761.CrossRefGoogle ScholarPubMed
Wright, JR, Ung, YC, Julian, JA, et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2007; 25:1027–1032.CrossRefGoogle ScholarPubMed
Smith, RE Jr., Aapro, MS, Ludwig, H, et al. Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2008; 26:1040–1050.Google Scholar
Khorana, AA, Francis, CW, Blumberg, N, et al. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Archives of Internal Medicine. 2008; 168:2377–2381.Google Scholar
Grant, MD, Piper, M, Bohlius, J, et al. Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update. AHRQ Comparative Effectiveness Reviews. Rockville (MD); 2013.Google Scholar
FDA Briefing Document Oncologic Drugs Advisory Committee. 2008 [accessed May 26, 2017]. Available from: www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4345b2-01-FDA.pdf.Google Scholar
Bohlius, J, Schmidlin, K, Brillant, C, et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet. 2009; 373:1532–1542.Google Scholar
Pfeffer, MA, Burdmann, EA, Chen, CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. The New England Journal of Medicine. 2009; 361:2019–2032.Google Scholar
Henke, M, Laszig, R, Rube, C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003; 362:1255–1260.CrossRefGoogle ScholarPubMed
Leyland-Jones, B, Semiglazov, V, Pawlicki, M, et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005; 23:5960–5972.Google Scholar
Untch, M, von Minckwitz, G, Konecny, GE, et al. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer–outcome on prognosis. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO. 2011; 22:1999–2006.Google Scholar
Leyland-Jones, B, Bondarenko, I, Nemsadze, G, et al. A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2016; 34:1197–1207.CrossRefGoogle ScholarPubMed
McKinney, M, Arcasoy, MO. Erythropoietin for oncology supportive care. Experimental Cell Research. 2011; 317:1246–1254.CrossRefGoogle ScholarPubMed
Rizzo, JD, Brouwers, M, Hurley, P, et al. American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood. 2010; 116:4045–4059.Google Scholar
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Cancer- and Chemotherapy-Induced Anemia, updated November 16, 2016 [accessed May 26, 2017]. Version 2.2017. Available from: www.nccn.org/professionals/physician_gls/pdf/anemia.pdf.Google Scholar
Engert, A, Josting, A, Haverkamp, H, et al. Epoetin alfa in patients with advanced-stage Hodgkin’s lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2010; 28:2239–2245.Google Scholar
Moebus, V, Jackisch, C, Schneeweiss, A, et al. Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial. Journal of the National Cancer Institute. 2013; 105:1018–1026.Google Scholar
Schrijvers, D, De Samblanx, H, Roila, F, E.G.W. Group. Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO. 2010; 21(Suppl)5:v244–v247.Google Scholar
Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy: National Institute for Health and Clinical Excellence technology appraisal guidance TA323; 2014 [accessed May 26, 2017]. Available from: www.nice.org.uk/guidance/ta323.Google Scholar
References
Gibson, CJ, Kennedy, JA, Nikiforow, S, Kuo, FC, Alyea, EP, Ho, V, Ritz, J, Soiffer, R, Antin, JH, Lindsley, RC. Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias. Blood. 2017;130:91–94.Google Scholar
Gibson, CJ, Lindsley, RC, Tchekmedyian, V, Mar, BG, Shi, J, et al. Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. Journal of Clinical Oncology. 2017;35:1598–1605.CrossRefGoogle ScholarPubMed
Larocca, A, Piaggio, G, Podesta, M, et al. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica. 2006; 91:935–940.Google ScholarPubMed
Schapira, L, Antin, JH, Ransil, BJ, et al. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood. 1990; 76:2354–2359.Google Scholar
Miller, CB, Lazarus, HM. Erythropoietin in stem cell transplantation. Bone Marrow Transplantation. 2001; 27:1011–1016.CrossRefGoogle ScholarPubMed
Wu, CJ, Gladwin, M, Tisdale, J, et al. Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis. British Journal of Haematology. 2007; 139:504–507.CrossRefGoogle ScholarPubMed
Wu, CJ, Krishnamurti, L, Kutok, JL, et al. Evidence for ineffective erythropoiesis in severe sickle cell disease. Blood. 2005; 106:3639–3645.Google Scholar
Benjamin, RJ, Antin, JH. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion. 1999; 39:1273–1274.Google Scholar
Benjamin, RJ, McGurk, S, Ralston, MS, Churchill, WH, Antin, JH. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion. 1999; 39:179–187.Google Scholar
Bolan, CD, Childs, RW, Procter, JL, Barrett, AJ, Leitman, SF. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. British Journal of Haematology. 2001; 112:787–795.Google Scholar
Nadarajah, L, Ashman, N, Thuraisingham, R, Barber, C, Allard, S, Green, L. Literature review of passenger lymphocyte syndrome following renal transplantation and two case reports. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2013; 13:1594–1600.Google Scholar
Young, PP, Goodnough, LT, Westervelt, P, Diersio, JF. Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2001; 27:1305–1310.CrossRefGoogle ScholarPubMed
Jodele, S, Zhang, K, Zou, F, Laskin, B, Dandoy, CE, Myers, KC, Lane, A, Meller, J, Medvedovic, M, Chen, J, Davies, SM. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood. 2016;127:989–996.Google Scholar
English, J, Evan, A, Houghton, DC, Bennett, WM. Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation. 1987; 44:135–141.Google Scholar
Guinan, EC, Tarbell, NJ, Niemeyer, CM, Sallan, SE, Weinstein, HJ. Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood. 1988; 72:451–455.Google Scholar
Mii, A, Shimizu, A, Kaneko, T, et al. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Pathology International. 2011; 61:518–527.Google Scholar
Ho, VT, Cutler, C, Carter, S, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2005; 11:571–575.CrossRefGoogle ScholarPubMed
Ruutu, T, Barosi, G, Benjamin, RJ, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007; 92:95–100.Google Scholar
Daikeler, T, Labopin, M, Ruggeri, A, et al. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2013; 121:1059–1064.Google Scholar
Rovira, J, Cid, J, Gutierrez-Garcia, G, et al. Fatal Immune Hemolytic Anemia Following Allogeneic Stem Cell Transplantation: report of 2 Cases and Review of Literature. Transfusion Medicine Reviews 2013; 27:166–170.CrossRefGoogle ScholarPubMed
Krishnan, A, Bhatia, S, Slovak, ML, et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood. 2000; 95:1588–1593.Google Scholar
Friedberg, JW, Neuberg, D, Stone, RM, et al. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin’s lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1999; 17:3128–3135.Google Scholar
Hertenstein, B, Hambach, L, Bacigalupo, A, et al. Development of leukemia in donor cells after allogeneic stem cell transplantation – a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2005; 90:969–975.Google Scholar
Asano, T, Kogawa, K, Morimoto, A, et al. Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan. Pediatric Blood & Cancer. 2012; 59:110–114.Google Scholar
van Esser, JW, van der Holt, B, Meijer, E, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT. Blood. 2001; 98:972–978.Google Scholar
References
Vanasse, GJ, Berliner, N. Anemia in elderly patients: an emerging problem for the 21st century. Hematology Am Soc Hematol Educ Program. 2010; 2010:271–275. PubMed PMID: 21239805. Epub 2011/01/18.Google Scholar
Blanc, BFC, Hallberg, L, et al. Nutritional anaemias. Report of a WHO Scientific Group. WHO Tech Rep Ser. 1968; 405:1–40.Google Scholar
Guralnik, JM, Eisenstaedt, RS, Ferrucci, L, Klein, HG, Woodman, RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004 Oct 15; 104(8):2263–2268. PubMed PMID: 15238427. Epub 2004/07/09.Google Scholar
Moore, KL, Boscardin, WJ, Steinman, MA, Schwartz, JB. Age and sex variation in prevalence of chronic medical conditions in older residents of U.S. nursing homes. J Am Geriatr Soc. 2012 Apr;60(4):756–764. PubMed PMID: 22463062. Epub 2012/04/03.CrossRefGoogle ScholarPubMed
Patel, KV. Epidemiology of anemia in older adults. Semin Hematol. 2008 Oct;45(4):210–217. PubMed PMID: 18809090. Epub 2008/09/24.Google Scholar
Paller, CJ, Shiels, MS, Rohrmann, S, Menke, A, Rifai, N, Nelson, WG, et al. Association between sex steroid hormones and hematocrit in a nationally representative sample of men. J Androl. 2012 Nov–Dec;33(6):1332–1341. PubMed PMID: 22604627. Epub 2012/05/19.Google Scholar
Beutler, E, West, C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood. 2005 Jul 15; 106(2):740–745. PubMed PMID: 15790781. Epub 2005/03/26.Google Scholar
Thomson, CA, Stanaway, JD, Neuhouser, ML, Snetselaar, LG, Stefanick, ML, Arendell, L, et al. Nutrient intake and anemia risk in the women’s health initiative observational study. J Am Diet Assoc. 2011 Apr;111(4):532–541. PubMed PMID: 21443985. Epub 2011/03/30.Google Scholar
Patel, KV, Longo, DL, Ershler, WB, Yu, B, Semba, RD, Ferrucci, L, et al. Haemoglobin concentration and the risk of death in older adults: differences by race/ethnicity in the NHANES III follow-up. Br J Haematol. 2009 May;145(4):514–523. PubMed PMID: 19344387. Epub 2009/04/07.CrossRefGoogle Scholar
Semba, RD, Ricks, MO, Ferrucci, L, Xue, QL, Chaves, P, Fried, LP, et al. Types of anemia and mortality among older disabled women living in the community: the Women’s Health and Aging Study I. Aging Clin Exp Res. 2007 Aug;19(4):259–264. PubMed PMID: 17726354. Epub 2007/08/30.Google Scholar
Woodman, R, Ferrucci, L, Guralnik, J. Anemia in older adults. Curr Opin Hematol. 2005 Mar;12(2):123–128. PubMed PMID: 15725902.Google ScholarPubMed
Kikuchi, M, Inagaki, T, Shinagawa, N. Five-year survival of older people with anemia: variation with hemoglobin concentration. J Am Geriatr Soc. 2001 Sep;49(9):1226–1228. PubMed PMID: 11559383.CrossRefGoogle ScholarPubMed
Guralnik, JM, Ershler, WB, Schrier, SL, Picozzi, VJ. Anemia in the elderly: a public health crisis in hematology. Hematology (Am Soc Hematol Educ Program). 2005:528–532. PubMed PMID: 16304431.Google Scholar
Willems, JM, den Elzen, WP, Vlasveld, LT, Westendorp, RG, Gussekloo, J, de Craen, AJ, et al. No increased mortality risk in older persons with unexplained anaemia. Age Ageing. 2012 Jul;41(4):501–506. PubMed PMID: 22417980. Epub 2012/03/16.Google Scholar
Tettamanti, M, Lucca, U, Gandini, F, Recchia, A, Mosconi, P, Apolone, G, et al. Prevalence, incidence and types of mild anemia in the elderly: the “Health and Anemia” population-based study. Haematologica. 2010 Nov;95(11):1849–1856. PubMed PMID: 20534701. PubMed Central PMCID: 2966906. Epub 2010/06/11.Google Scholar
Ferrucci, L, Corsi, A, Lauretani, F, Bandinelli, S, Bartali, B, Taub, DD, et al. The origins of age-related proinflammatory state. Blood. 2005 Mar 15; 105(6):2294–2299. PubMed PMID: 15572589. Epub 2004/12/02.Google Scholar
Furst, DE, Kay, J, Wasko, MC, Keystone, E, Kavanaugh, A, Deodhar, A, et al. The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Rheumatology (Oxford). 2013 Jul 9. PubMed PMID: 23838027. Epub 2013/07/11. Eng.Google Scholar
Vanasse, GJ, Jeong, JY, Tate, J, Bathulapalli, H, Anderson, D, Steen, H, et al. A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease. Blood. Nov 17; 118(20):5401–5408. PubMed PMID: 21926355. Epub 2011/09/20.CrossRefGoogle Scholar
Hubbard, RE, Sinead O’Mahony, M, Woodhouse, KW. Erythropoietin and anemia in aging and frailty. J Am Geriatr Soc. 2008 Nov;56(11):2164–2165. PubMed PMID: 19016962. Epub 2008/11/20.CrossRefGoogle ScholarPubMed
Chung, B, Matak, P, McKie, AT, Sharp, P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr. 2007 Nov;137(11):2366–2370. PubMed PMID: 17951471. Epub 2007/10/24.CrossRefGoogle ScholarPubMed
Ferrucci, L, Semba, RD, Guralnik, JM, Ershler, WB, Bandinelli, S, Patel, KV, et al. Proinflammatory state, hepcidin, and anemia in older persons. Blood. 2010 May 6; 115(18):3810–3816. PubMed PMID: 20081092. Epub 2010/01/19.Google Scholar
Perlstein, TS, Pande, R, Berliner, N, Vanasse, GJ. Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation. Blood. Mar 10; 117(10):2800–2806. PubMed PMID: 21239700. Epub 2011/01/18.Google Scholar
Hong, CH, Falvey, C, Harris, TB, Simonsick, EM, Satterfield, S, Ferrucci, L, et al. Anemia and risk of dementia in older adults: Findings from the Health ABC study. Neurology. Aug 6; 81(6):528–533. PubMed PMID: 23902706. Epub 2013/08/02.Google Scholar
Deal, JA, Carlson, MC, Xue, QL, Fried, LP, Chaves, PH. Anemia and 9-year domain-specific cognitive decline in community-dwelling older women: The Women’s Health and Aging Study II. J Am Geriatr Soc. 2009 Sep;57(9):1604–1611. PubMed PMID: 19682133. Epub 2009/08/18.Google Scholar
Yavuz, BB, Cankurtaran, M, Haznedaroglu, IC, Halil, M, Ulger, Z, Altun, B, et al. Iron deficiency can cause cognitive impairment in geriatric patients. J Nutr Health Aging. 2012 Mar;16(3):220–224. PubMed PMID: 22456776. Epub 2012/03/30.Google Scholar
Chang, SS, Weiss, CO, Xue, QL, Fried, LP. Patterns of comorbid inflammatory diseases in frail older women: the Women’s Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci. Apr;65(4):407–413. PubMed PMID: 19933749. Epub 2009/11/26.Google Scholar
Adams, KF Jr., Patterson, JH, Oren, RM, Mehra, MR, O’Connor, CM, Pina, IL, et al. Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. Am Heart J. 2009 May;157(5):926–932. PubMed PMID: 19376323. Epub 2009/04/21.Google Scholar
Shah, R, Agarwal, AK. Anemia associated with chronic heart failure: current concepts. Clin Interv Aging. 2013 8:111–122. PubMed PMID: 23403618. Epub 2013/02/14.Google Scholar
Nanas, JN, Matsouka, C, Karageorgopoulos, D, Leonti, A, Tsolakis, E, Drakos, SG, et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol. 2006 Dec 19; 48(12):2485–2489. PubMed PMID: 17174186. Epub 2006/12/19.Google Scholar
Toblli, JE, Lombrana, A, Duarte, P, Di Gennaro, F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol. 2007 Oct 23; 50(17):1657–1665. PubMed PMID: 17950147. Epub 2007/10/24.Google Scholar
Anker, SD, Comin, Colet J, Filippatos, G, Willenheimer, R, Dickstein, K, Drexler, H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009 Dec 17; 361(25):2436–2448. PubMed PMID: 19920054. Epub 2009/11/19.Google Scholar
Richardson, CL, Delehanty, LL, Bullock, GC, Rival, CM, Tung, KS, Kimpel, DL, et al. Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response. J Clin Invest. 2013 Aug 1; 123(8):3614–3623. PubMed PMID: 23863711. Epub 2013/07/19.Google Scholar
Den Elzen, WP, Martin-Ruiz, C, von Zglinicki, T, Westendorp, RG, Kirkwood, TB, Gussekloo, J. Telomere length and anaemia in old age: results from the Newcastle 85-plus Study and the Leiden 85-plus Study. Age Ageing. Jul;40(4):494–500. PubMed PMID: 21622673. Epub 2011/05/31.CrossRefGoogle Scholar
References
United Nations Children’s Fund, University, and WHO. Iron Deficiency Anaemia. Assessment, Prevention, and Control. A Guide for Programme Managers. Geneva (Switzerland): World Health Organization; 2001.Google Scholar
Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the united states. MMWR Recomm Rep. 1998; 47(RR-3):1–29.Google Scholar
World Health Organization. Nutritional anaemias. Report of a WHO scientific group 1968. (WHO Technical Report Series, No.405). http://whqlibdoc.who.int/trs/WHO_TRS_405.pdf (Accessed March 13, 2013).Google Scholar
Milman, N. Prepartum anaemia: prevention and treatment. Ann Hematol. 2008; 87(12):949–959.Google Scholar
Bernstein, IM, Ziegler, W, and Badger, GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol 97(5);669–672.Google Scholar
Andrews, NC. Forging a field: the golden age of iron biology. Blood. 2008; 112(2):219–230.Google Scholar
Scholl, TO et al. Anemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr. 1992; 55(5):985–988.Google Scholar
Cambpell, BA. Megaloblastic anemia in pregnancy. Clin Obstet Gynecol. 1995; 38(3):455–462.Google Scholar
Frenkel, EP, Yardley, DA. Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecology. Hematol Oncol Clin N Am. 2000; 14(5):1079–1100.Google Scholar
Rust, OA and Perry, KG. Pregnancy complicated by sickle hemoglobinopathy. Clin Obstet Gynecol. 1995; 38(3):472–484.Google Scholar
Rogers, DT and Molokie, R. Sickle disease in pregnancy. Obstet Gynecol Clin North Am. 2010; 37(2):223–237.Google Scholar
Fleming, AF. Maternal anemia and fetal outcome in pregnancies complicated by thalassemia minor and “stomatocytosis.” Am J Obstet Gynecol. 1973; 116(3):309–319.CrossRefGoogle ScholarPubMed
Kilpatrick, SJ and Laros, RK. Thalassemia in pregnancy. Clin Obstet Gynecol. 1995; 38(3):485–496.Google Scholar
Mordel, N et al. Successful full-term pregnancy in homozygous β-thalassemia major: case report and review of the literature. Obstet Gynecol. 1989; 73(5):837–840.Google Scholar
Leduc, L. Hemolytic anemias in pregnancy. Clin Obstet Gynecol. 1995; 38(3):463–471.CrossRefGoogle ScholarPubMed
Lipschitz, DA, Cook, JO, Finch, CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974; 290(22):1213–1216.Google Scholar
Breymann, C et al. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Arch Gynecol Obstet. 2010; 282(5):577–580.Google Scholar
Van den Broek, NR et al. Iron status in pregnant women: which measurements are valid? Br J Haematol. 1998; 103(3):817–824.Google Scholar
Schwartz, WJ, Thurnau, GR. Iron deficiency anemia in pregnancy. Clin Obstet Gynecol. 38(3):443–454.Google Scholar
Taylor, DJ et al. Effect of iron supplementation on serum ferritin levels during and after pregnancy. Br J Obstet Gynaecol. 1982; 89(12):1011–1017.Google Scholar
Allen, LH. Nutritional supplementation for the pregnant woman. Clin Obstet Gynecol. 1994; 37(3):587–595.Google Scholar
Reveiz, L et al. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2011; 10:CD003094.Google Scholar
Auerbach, M et al. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficiency anemia. Am J Hematol. 2011; 86(10):860–862.CrossRefGoogle Scholar
Khalafallah, AA et al. Three-year follow-up of a randomized clinical trial of intravenous versus oral iron for anaemia in pregnancy. BMJ Open. 2012; 2(5):e000998.Google Scholar
Sifakis, S et al. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. Gynecol Obstet Invest. 2001; 51(3):150–156.Google Scholar
Koshy, M et al. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. N Engl J Med. 1988; 319(22):1447–1452.Google Scholar
References
Cartwright, GE. The anemia of chronic disorders. Seminars in Hematology. 1966 Oct; 3(4):351–375. PubMed PMID: 5341723.Google Scholar
Weiss, G, Goodnough, LT. Anemia of chronic inflammation. The New England Journal of Medicine. 2005 Mar 10; 352(10):1011–1023. PubMed PMID: 15758012.Google Scholar
Weinberg, ED. Iron withholding: a defense against infection and neoplasia. Physiological Reviews. 1984 Jan; 64(1):65–102. PubMed PMID: 6420813.Google Scholar
Means, RT Jr. Hepcidin and iron regulation in health and disease. The American Journal of the Medical Sciences. 2013 Jan; 345(1):57–60. PubMed PMID: 22627267. PubMed Central PMCID: 3430792.Google Scholar
Gangat, N, Wolanskyj, AP. Anemia of chronic inflammation. Seminars in Hematology. 2013 Jul; 50(3):232–238. PubMed PMID: 23953340.Google Scholar
Nurko, S. Anemia in chronic kidney disease: causes, diagnosis, treatment. Cleveland Clinic Journal of Medicine. 2006 Mar; 73(3):289–297. PubMed PMID: 16548452.Google Scholar
Yasunaga, C, Matsuo, K, Yanagida, T, Matsuo, S, Nakamoto, M, Goya, T. Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism. American Journal of Surgery. 2002 Feb; 183(2):199–204. PubMed PMID: 11918889.Google Scholar
Romero-Gomez, M, Berenguer, M, Molina, E, Calleja, JL. Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges, opportunities and recommendations. Journal of Hematology. 2013 Jul:15. PubMed PMID: 23867320.Google Scholar
Handin, RI, Lux, SE, Stossel, TP. Blood: Principles and Practice of Hematology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:xii, 2304.Google Scholar
van Veldhuisen, DJ, Anker, SD, Ponikowski, P, Macdougall, IC. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nature Reviews Cardiology. 2011 Sep; 8(9):485–493. PubMed PMID: 21629210.Google Scholar
Groenveld, HF, Januzzi, JL, Damman, K, van Wijngaarden, J, Hillege, HL, van Veldhuisen, DJ, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. Journal of the American College of Cardiology. 2008 Sep 2; 52(10):818–827. PubMed PMID: 18755344.Google Scholar
Dicato, M, Plawny, L, Diederich, M. Anemia in cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO. 2010 Oct; 21 Suppl 7:vii, 167–172. PubMed PMID: 20943610.Google Scholar
Kliger, AS, Foley, RN, Goldfarb, DS, Goldstein, SL, Johansen, K, Singh, A, et al. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation. 2013 Jul 25. PubMed PMID: 23891356.Google Scholar
Bohlius, J, Schmidlin, K, Brillant, C, Schwarzer, G, Trelle, S, Seidenfeld, J, et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet. 2009 May 2; 373(9674):1532–1542. PubMed PMID: 19410717.CrossRefGoogle Scholar
Rizzo, JD, Brouwers, M, Hurley, P, Seidenfeld, J, Arcasoy, MO, Spivak, JL, et al. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2010 Nov 20; 28(33):4996–5010. PubMed PMID: 20975064.Google Scholar
Sun, CC, Vaja, V, Babitt, JL, Lin, HY. Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic inflammation and anemia of inflammation. American Journal of Hematology. 2012 Apr; 87(4):392–400. PubMed PMID: 22290531. PubMed Central PMCID: 3653431.CrossRefGoogle ScholarPubMed
Schwoebel, F, van Eijk, LT, Zboralski, D, Sell, S, Buchner, K, Maasch, C, et al. The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. Blood. 2013 Mar 21; 121(12):2311–2315. PubMed PMID: 23349391. PubMed Central PMCID: 3606066.Google Scholar
References
Tinmouth, A, Chin-Yee, I. The clinical consequences of the red cell storage lesion. Transfus Med Rev. 2001; 15:91–107.Google Scholar
Heddle, NM, Cook, RJ, Arnold, DM. et al. Effect of short-term vs. long-term blood storage on mortality after transfusion. N Eng J Med. 2016; 375:1937–1945.CrossRefGoogle ScholarPubMed
Sweeney, JD. Standardization of the red cell product. Transfusion and Apheresis Science. 2006; 34:213–218.Google Scholar
Wallis, JP, Wells, AW, Chapman, CE. Changing indications for red cell transfusion from 2000 to 2004 in the North of England. Transfus Med. 2006; 16:411–417.Google Scholar
The collection, testing and use of blood products in Europe (2007), Council of Europe Publishing, Strasbourg, 2007, www.edqm.eu.Google Scholar
Report of the U.S. Department of Health and Human Services. The 2011 National Blood Collection and Utilization Survey Report. Washington, DC: U.S. Department of Health and Human Services, 2011.Google Scholar
Elizalde, JI, Clemente, JL, Marin, J, et al. Early changes in hemoglobin and hematocrit levels after packed red cells transfusion in patients with acute anemia. Transfusion. 1997; 37:573–576.Google Scholar
Hess, JR, Dutton, RBH, Holcomb, JB Scalea, TM. Giving plasma at a 1:1 ratio with red cells in resuscitation: Who might benefit? Transfusion. 2008; 48:1763–1765.Google Scholar
Villanueva, C, Colomo, A, Bosch, A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Eng J Med. 2013; 368:11–21.Google Scholar
Hebert, PC, Wells, G, Blajchmann, MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Eng J Med. 1999; 340:409–417.Google Scholar
Rao, SV, Jollis, JG, Harrington, RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555–1562.CrossRefGoogle ScholarPubMed
Chatterjee, S, Wetterslev, J, Sharma, A, et al. Association of blood transfusion in increase mortality in myocardial infarction: meta-analysis and diversity adjusted study sequential analysis. JAMA Intern Med. 2013; 173:132–139.Google Scholar
Cooper, HA, Rao, SV, Greenberg, MD, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction. Am J Cardiol. 2011; 108:1108–1111.Google Scholar
Carson, JL, Liberal or restrictive transfusion in high risk patients after hip surgery. N Eng J Med. 2011; 1:1–10.Google Scholar
Sweeney, JD, Kouttab, N, Kurtis, JD. Stored red cell supernatant facilitates thrombin generation. Transfusion. 2009; 49:1569–1579.Google Scholar
Carson, JL, Grossman, BJ, Kleinman, S, et al. Red blood transfusion: A clinical practice guideline from the AABB. Ann Intern Med. 2012; 157:49–58.Google Scholar
LeGolvan, M, Pilz, J, Sweeney, JD. Should patients with malignancies receive phenotyped matched red cells? Transfusion. 2005 ;45:132A.Google Scholar
Sanz, C, Nomdedeu, M, Belkaid, M, et al. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion. 2013; 53:710–715.Google Scholar
Tahhan, HR, Holbrook, CT, Braddy, LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion. 1994; 34(7):562–569.Google Scholar
Chou, ST, Jackson, T, Vege, S, et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. 2013; DOI:10.1182/Blood-2013-03-490623.Google Scholar
Ziman, A, Cohn, C, Carey, PM et al. Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice. Transfusion. 2017; 57:463–477.Google Scholar
Anstee, D. Red cell genotyping and the future of pretransfusion testing. Blood. 2009; 114:248–256.Google Scholar
Miller, ST. How I treat acute chest syndrome in children with sickle cell disease. Blood. 2011; 117:5297–5305.Google Scholar
Spaete, JE, Rich, J, Sweeney, JD. Red cell exchange for babesiosis in Rhode Island. J Clin Apheresis. 2009; 24:97–105.Google Scholar
Sweeney, JD. Universal leukoreduction of cellular blood components in 2001? Yes. Am J Clin Pathol. 2001; 115:666–673.Google Scholar
Treleaven, J, Gennery, A, Marsh, J, et al. Guidelines for the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. Br J Haem. 2010; 152:35–51.Google Scholar
Moroff, G, Holme, S, AuBuchon, JP, et al. Viability and in vitro properties of gamma irradiated AS-1 red blood cell. Transfusion. 1999; 39:128–134.Google Scholar
Goldfinger, D, Lowe, C. Prevention of adverse reactions to blood transfusion by the administration of saline-washed red blood cells. Transfusion. 1981; 21:277–280.Google Scholar
Luban, NLC, Strauss, RG, Hume, HA. Commentary on the safety of red cells preserved in extended-storage media for neonatal transfusions. Transfusion. 1991; 31:229–235.Google Scholar
Lacroix, J, Hebert, PC, Hutchinson, JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Eng J Med. 2007; 356:1609–1619.CrossRefGoogle ScholarPubMed
References
Mazzei, CA, Popovski, MA, Kopko, PM. Noninfectious complications of blood transfusion. In: Roback, JD, Grossman, BJ, Harris, T, Hillyer, CD, eds. Technical Manual. 17 ed. Bethesda: AABB; 2011; 727–762.Google Scholar
Sink, BLS. Administration of blood components. In: Roback, JD, Grossman, BJ, Harris, T, Hillyer, CD, eds. Technical Manual. 17 ed. Bethesda: AABB; 2011; 617–629.Google Scholar
Tobian, AA, King, KE, Ness, PM. Transfusion premedications: a growing practice not based on evidence. Transfusion. 2007 Jun; 47(6):1089–1096.Google Scholar
Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2015 [electronic document]. United States Food and Drug Administration Web Site. Available at: www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM518148.pdf. Accessed May 21, 2017.Google Scholar
Lozano, M, Cid, J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfusion Medicine Reviews. 2003 Jan; 17(1):57–68.CrossRefGoogle ScholarPubMed
Valbonesi, M, De Luigi, MC, Lercari, G, et al. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. The International Journal of Artificial Organs. 2000 Sep; 23(9):642–646.CrossRefGoogle ScholarPubMed
Hawkins, R. Discrepancy between visual and spectrophotometric assessment of sample haemolysis. Annals of Clinical Biochemistry. 2002 Sep; 39(Pt 5):521–522.Google Scholar
National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol Version 2.4 [electronic document]. 2017 January. In: CDC Web Site. Available at: www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf. Accessed May 21, 2017.Google Scholar
Giles, CM. The role of complement in immunohematology. Transfusion. 1989 Nov–Dec; 29(9):803–811.CrossRefGoogle ScholarPubMed
Tao, MH, Canfield, SM, Morrison, SL. The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain. The Journal of Experimental Medicine. 1991 Apr 1; 173(4):1025–1028.CrossRefGoogle ScholarPubMed
Tormey, CA, Stack, G. The persistence and evanescence of blood group alloantibodies in men. Transfusion. 2009 Mar; 49(3):505–512.Google Scholar
Pineda, AA, Vamvakas, EC, Gorden, LD, Winters, JL, Moore, SB. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion. 1999 Oct; 39(10):1097–1103.Google Scholar
Vichinsky, EP, Earles, A, Johnson, RA, Hoag, MS, Williams, A, Lubin, B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New England Journal of Medicine. 1990; 322(23):1617–1621.Google Scholar
Uhlmann, EJ, Shenoy, S, Goodnough, LT. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion. Transfusion. 2013 May 21. [Epub ahead of print].Google Scholar
Sowemimo-Coker, SO. Red blood cell hemolysis during processing. Transfusion Medicine Reviews. 2002 Jan; 16(1):46–60.Google Scholar
Shapira, Y, Vaturi, M, Sagie, A. Hemolysis associated with prosthetic heart valves: a review. Cardiology in Review. 2009 May–Jun; 17(3):121–124.Google Scholar
Marti-Carvajal, AJ, Sola, I, Gonzalez, LE, Leon de Gonzalez, G, Rodriguez-Malagon, N. Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions. The Cochrane Database of Systematic Reviews. 2010(6):CD007539.Google Scholar
Circular of Information: for the Use of Human Blood and Blood Components [electronic document]. Revised November 2013. In: AABB Web Site. Available at: www.aabb.org/tm/coi/Documents/coi1113.pdf. Accessed May 21, 2017.Google Scholar
Andrzejewski, C Jr., Popovsky, MA, Stec, TC, et al. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects? Transfusion. 2012 Nov; 52(11):2310–2320.Google Scholar
King, KE, Shirey, RS, Thoman, SK, Bensen-Kennedy, D, Tanz, WS, Ness, PM. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion. 2004 Jan; 44(1):25–29.Google Scholar
Toy, P, Popovsky, MA, Abraham, E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005; 33(4):721–726.Google Scholar
Popovsky, MA, Abel, MD, Moore, SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. The American Review of Respiratory Disease. 1983 Jul; 128(1):185–189.Google Scholar
Silliman, CC, Ambruso, DR, Boshkov, LK. Transfusion-related acute lung injury. Blood. 2005 Mar 15; 105(6):2266–2273.Google Scholar
Eder, AF, Herron, R, Strupp, A, et al. Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 2007 Apr; 47(4):599–607.Google Scholar
Toy, P, Gajic, O, Bacchetti, P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012 Feb 16; 119(7):1757–1767.Google Scholar
AABB Revises and Clarifies TRALI Risk Reduction Requirements. AABB Weekly Report [serial online]. 2013 Sept 27. Available at: www.aabb.org/resources/publications/weeklyreport/2013/Pages/wr130927.aspx. Accessed February 4, 2014.Google Scholar
Murphy, EL, Kwaan, N, Looney, MR, et al. Risk factors and outcomes in transfusion-associated circulatory overload. The American Journal of Medicine. 2013 Apr; 126(4):357 e329–e338.Google Scholar
Popovsky, MA. Pulmonary consequences of transfusion: TRALI and TACO. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis. 2006 Jun; 34(3):243–244.Google Scholar
Alam, A, Lin, Y, Lima, A, Hansen, M, Callum, JL. The prevention of transfusion-associated circulatory overload. Transfusion Medicine Reviews. 2013 Apr; 27(2):105–112.Google Scholar
Pandey, S, Vyas, GN. Adverse effects of plasma transfusion. Transfusion. 2012 May; 52 Suppl 1:65S–79S.Google Scholar
Kopko, PM, Holland, PV. Transfusion-related acute lung injury. British Journal of Haematology. 1999 May; 105(2):322–329.Google Scholar
Skeate, RC, Eastlund, T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Current Opinion in Hematology. 2007 Nov; 14(6):682–687.Google Scholar
Li, G, Daniels, CE, Kojicic, M, et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion. 2009 Jan; 49(1):13–20.Google Scholar
Tobian, AA, Sokoll, LJ, Tisch, DJ, Ness, PM, Shan, H. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion. 2008 Jun; 48(6):1143–1150.Google Scholar
Levy, GJ, Shabot, MM, Hart, ME, Mya, WW, Goldfinger, D. Transfusion-associated noncardiogenic pulmonary edema. Report of a case and a warning regarding treatment. Transfusion. 1986 May–Jun; 26(3):278–281.Google Scholar
Tobian, AA, Savage, WJ, Tisch, DJ, Thoman, S, King, KE, Ness, PM. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion. 2011 Aug; 51(8):1676–1683.Google Scholar
Hirayama, F. Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. British Journal of Haematology. 2013 Feb; 160(4):434–444.Google Scholar
Gilstad, CW. Anaphylactic transfusion reactions. Current Opinion in Hematology. 2003 Nov; 10(6):419–423.Google Scholar
Young, C, Chawla, A, Berardi, V, et al. Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program. Transfusion. 2012 Jul; 52(7):1523–1529.Google Scholar
Hillyer, CD, Josephson, CD, Blajchman, MA, Vostal, JG, Epstein, JS, Goodman, JL. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2003:575–589.Google Scholar
Brecher, ME, Means, N, Jere, CS, Heath, D, Rothenberg, S, Stutzman, LC. Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion. 2001 Apr; 41(4):477–482.Google Scholar
Murphy, WG, Foley, M, Doherty, C, et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sanguinis. 2008 Jul; 95(1):13–19.Google Scholar
Pelletier, JP, Transue, S, Snyder, EL. Pathogen inactivation techniques. Best practice & research. Clinical Haematology. 2006; 19(1):205–242.Google Scholar
Snyder, EL, Stramer, S, Benjamin, R. Safety of the blood supply – time to raise the bar. The New England Journal of Medicine. 2015; 372(20):1882–1885.Google Scholar
Seltsam, A, Muller, TH. Update on the use of pathogen-reduced human plasma and platelet concentrates. British Journal of Haematology. 2013 Aug; 162(4):442–454.Google Scholar
Anderson, KC, Weinstein, HJ. Transfusion-associated graft-versus-host disease. The New England Journal of Medicine. 1990 Aug 2; 323(5):315–321.Google Scholar
Fast, LD. Developments in the prevention of transfusion-associated graft-versus-host disease. British Journal of Haematology. 2012 Sep; 158(5):563–568.Google Scholar
Thuret, I. Post-transfusional iron overload in the haemoglobinopathies. Comptes Rendus Biologies. 2013 Mar; 336(3):164–172.Google Scholar
Sihler, KC, Napolitano, LM. Complications of massive transfusion. Chest. 2010 Jan; 137(1):209–220.Google Scholar
Padhi, P, Parihar, GS, Stepp, J, Kaplan, R. Post-transfusion purpura: a rare and life-threatening aetiology of thrombocytopenia. BMJ Case Reports. May 24, 2013. [published online].Google Scholar
Schwartz, J, Winters, JL, Padmanabhan, A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. Journal of Clinical Apheresis. 2013 Jul; 28(3):145–284.Google Scholar